OmniAb, Inc. Common StockOABI

OmniAb licenses cutting-edge discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Our technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for our partners' drug development efforts. At the heart of the OmniAb platform is what we call Biological Intelligence, which powers the immune systems of our proprietary, engineered transgenic animals to create optimized antibody candidates for human.

omniab.com